Ariv Biosciences Private Limited
About Ariv Biosciences Private Limited
Data last updated:
Ariv Biosciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 12 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U21001TG2020PTC140814.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Navinchandra Suresh Pawaskar and Raajitha Rao Jupally.
Its last annual general meeting (AGM) was held on 01 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2026, the company reported a revenue of ₹11.85 Lakh, a growth of 27% compared to the previous year. For the same year it recorded a net loss of ₹1.08 Lakh (net margin -9.2%) and EBITDA of -₹1.08 Lakh (EBITDA margin -9.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 16% over five years.
Company details
CIN history
Ariv Biosciences has one previous CIN (Corporate Identification Number): U74999TG2020PTC140814. The current CIN is U21001TG2020PTC140814, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21001TG2020PTC140814 | Current |
| U74999TG2020PTC140814 | Previous |
Contact details
Ariv Biosciences Private Limited's registered office is in Shaikpet, Telangana.
- Registered Address1 – 123 Sy. No. 79 8th Floor 3rd Block, My Home Hub Hi – Tech City Madhapur, Hyderabad, Telangana, India – 500081
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ariv Biosciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Ariv Biosciences Private Limited, buy the company report.
Financials of Ariv Biosciences Private Limited
FY 2026 filings availableAriv Biosciences Private Limited reported revenue of ₹11.85 Lakh (up 27% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 27% growth in the latest year. EBITDA rose 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.2% | ||||
| Net Profit Margin | -9.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ariv Biosciences Private Limited, buy the company report.
Board of directors of Ariv Biosciences Private Limited
Ariv Biosciences has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Navinchandra Suresh Pawaskar Also directs: Ihomeo Software Private Limited, Parimal Projects Private Limited | Director | 12 Jun 2020 | 6 Years 4 Months | Current |
| Raajitha Rao Jupally Also directs: Bhuvija Consultancy Services LLP, Manak Technocities Private Limited, Pramada Infra Projects Private Limited and 1 more | Director | 02 Apr 2025 | 1 Years 7 Months | Current |
| Annapurna Polsani Also directs: Aara Lake Side LLP | Director | 02 Apr 2025 | 1 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Ariv Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ariv Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ariv Biosciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ariv Biosciences Private Limited has 6 board changes on record since 2020: 3 appointments and 3 cessations. The latest: Reetha Krishnan ceased to be Director on 25 Jul 2025.
Frequently asked questions
Ariv Biosciences is an active private limited company based in Hyderabad, Telangana, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 12 June 2020 (6+ years old) and is registered under CIN U21001TG2020PTC140814.
Ariv Biosciences has 3 current directors:
- Navinchandra Suresh Pawaskar - Director
- Raajitha Rao Jupally - Director
- Annapurna Polsani - Director
The latest financial statements of Ariv Biosciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 01 June 2026. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Ariv Biosciences is U21001TG2020PTC140814. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ariv Biosciences was incorporated on 12 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Reetha Krishnan ceased to be Director on 25 Jul 2025. Jupally Raajitha Rao ceased to be Additional Director on 29 May 2025. Polsani Annapurna ceased to be Additional Director on 29 May 2025. Ariv Biosciences has 6 board changes on record in total.
The registered office of Ariv Biosciences is at 1 – 123 Sy. No. 79 8th Floor 3rd Block, My Home Hub Hi – Tech City Madhapur, Hyderabad, Telangana, India – 500081.
Ariv Biosciences operates in the healthcare industry, in the preventive health services segment.
Ariv Biosciences can be reached at its registered office: 1 – 123 Sy. No. 79 8th Floor 3rd Block, My Home Hub Hi – Tech City Madhapur, Hyderabad, Telangana, India – 500081.
Ariv Biosciences is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
